R333 (Pantoprazole sodium delayed release 40 mg)
Pill imprint R333 has been identified as Pantoprazole sodium delayed release 40 mg.
Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- R333
- Strength:
- 40 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0333
- Inactive Ingredients:
- ammonia
calcium stearate
crospovidone
hydroxypropyl cellulose
hypromelloses
ferrosoferric oxide
isopropyl alcohol
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
butyl alcohol
polyethylene glycol 400
propylene glycol
shellac
sodium carbonate
ferric oxide yellow
magnesium silicate
titanium dioxide
triethyl citrate
zein
alcohol
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-6235 | Major Pharmaceuticals |
Note: Inactive ingredients may vary.
More about pantoprazole
Consumer resources
- Pantoprazole,
- Pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
- Other brands: Protonix, Protonix IV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
